AGP Picks
View all

AGP Executive Report

Last update: 10 hours ago

AFCON Qualifying: Guinea-Bissau remain top of Group L with seven points, one ahead of Nigeria, after the Djurtus drew 1-1 with Madagascar. Nigeria revived its hopes with a 3-1 win over Tanzania and now faces the Taifa Stars again in Zanzibar on Tuesday. Only the group winner is guaranteed a place at AFCON 2027. Nigeria Team News: The Super Eagles completed their final training session in Zanzibar, but will be without Ademola Lookman, who returned to Spain with a knee injury. A Nigeria win would increase pressure on Guinea-Bissau as the group race tightens.

Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.

AGP Wire

fallback image
Oct. 21, 2026

Stand Up for Science says controversial Hep B vaccine study in Guinea-Bissau is canceled

AGP

fallback image
Oct. 15, 2026

Stand Up for Science publishes Guinea-Bissau vaccine trial investigation

AGP

fallback image
Oct. 13, 2026

Stand Up for Science pushes Congress to halt CDC vaccine study in Guinea-Bissau

AGP

fallback image
Oct. 8, 2026

Stand Up for Science blasts CDC plan to revive Guinea-Bissau vaccine study

AGP


Perspectify logo Perspectify News

Learn about labels.

Labels
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate Press Release Service
filter

Filter

Source Label Filters

All labels are selected. Deselect any labels you want to hide from your feed.

Labels:

Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
Press Release Service
‘Dead on arrival’: Inside the university ethical approval of a controversial vaccine study

‘Dead on arrival’: Inside the university ethical approval of a controversial vaccine study


fallback image
Oct. 21, 2026

“A Huge Relief”: Stand Up for Science Celebrates Stopping Controversial Hep-B Vaccine Study in Guinea-Bissau

EIN Presswire

fallback image
Oct. 15, 2026

As CDC Renews Controversial Guinea-Bissau Vaccine Trial, Stand Up for Science Makes Its Field Investigation Public

EIN Presswire

fallback image
Oct. 8, 2026

Stand Up for Science Condemns CDC’s Attempts to Restart Controversial Vaccine Study in Guinea-Bissau

EIN Presswire

fallback image
Sep. 4, 2026

Đurić Confers with Guinea-Bissau’s Minister of Foreign Affairs

Ministry of Foreign Affairs of the Republic of Serbia

fallback image
Sep. 2, 2026

Đurić Confers with Guinea-Bissau’s Minister of Foreign Affairs

Ministry of Foreign Affairs of the Republic of Serbia

fallback image
Nov. 12, 2026

West African labour council opens a regional reflection on adequate wages with ILO support

International Labour Organization

More press releases

Video Stories

YouTube video thumbnail: The Dark Side to Africa's Beauty Boom
Play
The Dark Side to Africa's Beauty Boom
YouTube video thumbnail:  Pope Leo XIV Denounces the ‘Suffering and Humiliation’ of African Enslaved People
Play
Pope Leo XIV Denounces the ‘Suffering and Humiliation’ of African Enslaved People
YouTube video thumbnail: Discover Affinity Group Publishing
Play
Discover Affinity Group Publishing
YouTube video thumbnail: Africa CDC Says Ebola Outbreak Still out of Control After Six Months
Play
Africa CDC Says Ebola Outbreak Still out of Control After Six Months
YouTube video thumbnail: Why DR Congo Is Threatening to Quit a French-Speaking Bloc
Play
Why DR Congo Is Threatening to Quit a French-Speaking Bloc

Video Title

Sign up for:

Guinea Bissau Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

globe

Explore More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Guinea Bissau Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.